Niagen Bioscience, Inc.

NAGE · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

6 USD

Margin of Safety

+41.2 %

Rating

STARK

GESCHÄFTSMODELL Niagen Bioscience, Inc. develops and markets products based on nicotinamide riboside (NR) as well as related NAD+ precursor technologies and generates revenue primarily through the sale of dietary supplements and licensed active ingredients to pharmaceutical and consumer goods partners.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.